Hong Zhao - SciClone Pharmaceuticals Insider

SCLN -- USA Stock  

USD 11.15  0.00  0.00%

CEO of China Operations

Mr. Hong Zhao was appointed as Chief Executive Officer China Operations of Sciclone Pharmaceuticals, Inc., effective April 01, 2013. Mr. Zhao joined SciClone as Chief Executive Officer, China Operations, in April 2013. Prior to SciClone, from 2011 to 2013, Mr. Zhao served as Executive Vice President of Simcere Pharmaceutical Group, a manufacturer and supplier of pharmaceuticals in China, where he was responsible for all business operations and had direct reporting responsibility for medical affairs, market access, marketing and sales operations, training and personnel development. Prior to Simcere, from 1999 to 2011, Mr. Zhao held various positions at Novartis China, a health care products company, including most recently, Senior Vice President of Novartis Greater China and General Manager of Novartis Shanghai
Age: 50  CEO Since 2013      
650-358-3456  www.sciclone.com
Zhao earned a Bachelor of Medicine degree from Nanjing Medical College and an Executive Masters of Business Administration degree from China European International Business School in Shanghai.

Hong Zhao Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 11.28 % which means that it generated profit of $11.28 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 19.56 % meaning that it created $19.56 on every $100 dollars invested by stockholders.

Similar Executives

Found 5 records

CEO Since

Brenton SaundersAllergan plc
2016
Paul CampanelliEndo International plc
2016
Donald DeGolyerEndo International plc
N/A
Mark TrudeauMallinckrodt Public Limited Com
2013
Rajiv SilvaEndo International plc
N/A

Entity Summary

SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, offer therapies for oncology, infectious diseases, and cardiovascular disorders in the People?s Republic of China, the United States, and Hong Kong. SciClone Pharmaceuticals (SCLN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 590 people. SciClone Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

SciClone Pharmaceuticals Leadership Team

Charles Meng, VP
Richard Hawkins, Director
Gregg Lapointe, Director, MBA
Hong Zhao, CEO
Wilson Cheung, CFO
Nancy Chang, Director, Ph.D
Anthony Lapointe, Director, MBA
Lan Xie, CFO, MBA
Raymond Low, President, MBA
Robert King, President, Ph.D
Simon Li, Director, MBA
Jon Saxe, Chairman
Friedhelm Blobel, CEO, Ph.D

Stock Performance Indicators

Did you try this?

Run Balance Of Power Now
   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Balance Of Power

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
few days ago
Traded for 10.44
FBU   
Purchased over 300 shares of
few days ago
Traded for 6.24
JBH   
Purchased over 70 shares of
few days ago
Traded for 23.42
GNC   
Purchased over 200 shares of
few days ago
Traded for 8.1
SBM   
Purchased over 400 shares of
few days ago
Traded for 4.74
Also please take a look at World Market Map. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.